Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Review · April 22, 2024

Journey of von Hippel–Lindau E3 Ligase in PROTAC Design

European Journal of Medicinal Chemistry


Additional Info

European Journal of Medicinal Chemistry
Journey of Von Hippel-Lindau (VHL) E3 ligase in PROTACs design: From VHL ligands to VHL-based degraders
Eur J Med Chem 2024 Feb 05;265(xx)116041, N Setia, HTA Almuqdadi, M Abid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading